Cleared Special

K072894 - SURFLO WINGED INFUSION SET WITH NEEDLE ...

K072894 is the FDA 510(k) clearance for SURFLO WINGED INFUSION SET WITH NEEDLE ... by Terumo Europe N.V.. It is a Class 2 General Hospital device (product code FPA) cleared through the Special 510(k) pathway after a 26-day FDA review.

K072894 · Terumo Europe N.V. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2007
Decision
26d
Days
Class 2
Risk

K072894 is an FDA 510(k) clearance for the SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD). Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Terumo Europe N.V. (Leuven, BE). The FDA issued a Cleared decision on November 6, 2007 after a review of 26 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Terumo Europe N.V. devices

Submission Details

510(k) Number K072894 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2007
Decision Date November 06, 2007
Days to Decision 26 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
103d faster than avg
Panel avg: 129d · This submission: 26d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 446
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K072894.
V-LINK ANTIMICROBIAL LUER ACTIVATED DEVICE AND EXTENSION SETS WITH V-LINK ANTIMICROBIAL LUER ACTIVATED DEVICE
K081289 · Baxter Healthcare Corp · Aug 2008
SMARTPORT CT MP PORT ACCESS SYSTEM AND LIFEGUARD CT SAFETY INFUSION SET
K072375 · AngioDynamics, Inc. · Dec 2007
CLEARLINK ANTIMICROBIAL LUER ACTIVATED DEVICE (LAD) AND EXTENSION SETS WITH THE CLEARLINK ANTIMICROBIAL LUER ACTIVATED
K072576 · Baxter Healthcare Corp · Nov 2007
SPIROS
K070532 · Icu Medical, Inc. · Mar 2007
INTERLINK SYSTEM-T-CONNECTOR EXTENSION SET, MODEL 2N3326
K060074 · Baxter Healthcare Corp · Mar 2006
TEGO, MODEL D1000
K053106 · Icu Medical, Inc. · Jan 2006